‹ See all categories

New Creative Relevant Search filters Interleukin 2 Stock Photos and Images  (47) Narrow your search: Vectors | Cut Outs Page 1 of 1 Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180731.html Structure of human interleukin-2, 3D cartoon model isolated, white background Structure of human interleukin-2, 3D cartoon model isolated, white backgroundhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/structure-of-human-interleukin-2-3d-cartoon-model-isolated-white-background-image393158610.html Cancer immuno-therapy steps in 3d illustration Cancer immuno-therapy steps in 3d illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/cancer-immuno-therapy-steps-in-3d-illustration-image365392016.html Serine/threonine-protein kinase 10, an enzyme which can negatively regulate interleukin 2 expression in T-cells via the mitogen activated protein kina Serine/threonine-protein kinase 10, an enzyme which can negatively regulate interleukin 2 expression in T-cells via the mitogen activated protein kinahttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/serinethreonine-protein-kinase-10-an-enzyme-which-can-negatively-regulate-interleukin-2-expression-in-t-cells-via-the-mitogen-activated-protein-kina-image262850298.html Tacrolimus (fujimycin FK-506) immunosuppressant drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as Tacrolimus (fujimycin FK-506) immunosuppressant drug molecule Stylized skeletal formula (chemical structure) Atoms are shown ashttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-tacrolimus-fujimycin-fk-506-immunosuppressant-drug-molecule-stylized-101777829.html differentiation of T cells, from Th0 cells to Th1 or Th2 differentiation of T cells, from Th0 cells to Th1 or Th2https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-differentiation-of-t-cells-from-th0-cells-to-th1-or-th2-96115055.html Tacrolimus immunosuppressant drug molecule, illustration Tacrolimus immunosuppressant drug molecule, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-immunosuppressant-drug-molecule-illustration-image345478028.html Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180712.html Tacrolimus immunosuppressant drug molecule, illustration Tacrolimus immunosuppressant drug molecule, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-immunosuppressant-drug-molecule-illustration-image345478061.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180032.html Tacrolimus immunosuppressant drug molecule, illustration Tacrolimus immunosuppressant drug molecule, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-immunosuppressant-drug-molecule-illustration-image345478067.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180010.html Tacrolimus immunosuppressant drug molecule, illustration Tacrolimus immunosuppressant drug molecule, illustrationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-immunosuppressant-drug-molecule-illustration-image345478064.html Rapamycin (sirolimus) immunosuppressive drug molecule Used to prevent transplant rejection and in coronary stent coating Rapamycin (sirolimus) immunosuppressive drug molecule Used to prevent transplant rejection and in coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-101777794.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180008.html Rapamycin (sirolimus) immunosuppressive drug molecule Used to prevent transplant rejection and in coronary stent coating Rapamycin (sirolimus) immunosuppressive drug molecule Used to prevent transplant rejection and in coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-101777879.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Blue skeletal formula on wh Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Blue skeletal formula on whhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-transplant-rejection-and-in-coronary-stent-coating-blue-skeletal-formula-on-wh-image367358633.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180022.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. White skeletal formula on d Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. White skeletal formula on dhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-transplant-rejection-and-in-coronary-stent-coating-white-skeletal-formula-on-d-image367358688.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180011.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula ( Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula (https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-transplant-rejection-and-in-coronary-stent-coating-stylized-skeletal-formula-image367358641.html Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab. Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-receptor-alpha-chain-cd25-extracellular-domain-cd25-141180033.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula ( Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula (https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-transplant-rejection-and-in-coronary-stent-coating-stylized-skeletal-formula-image367358685.html Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180730.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula ( Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Stylized skeletal formula (https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-transplant-rejection-and-in-coronary-stent-coating-stylized-skeletal-formula-image367358434.html Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180727.html Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180744.html Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering. Interleukin 2 (IL-2) cytokine protein. Aldesleukin is a recombinant analog of IL-2 that is used in the treatment of cancer. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-2-il-2-cytokine-protein-aldesleukin-is-a-recombinant-analog-141180707.html Tacrolimus (fujimycin, FK-506) immunosuppressant drug molecule. Skeletal formula. Tacrolimus (fujimycin, FK-506) immunosuppressant drug molecule. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-fujimycin-fk-506-immunosuppressant-drug-molecule-skeletal-formula-image185310667.html Tacrolimus (fujimycin, FK-506) immunosuppressant drug molecule. Skeletal formula. Tacrolimus (fujimycin, FK-506) immunosuppressant drug molecule. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tacrolimus-fujimycin-fk-506-immunosuppressant-drug-molecule-skeletal-formula-image185380877.html Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody. Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-basiliximab-monoclonal-antibody-drug-targets-cd25-and-is-used-to-prevent-147293022.html Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody. Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-basiliximab-monoclonal-antibody-drug-targets-cd25-and-is-used-to-prevent-147292988.html Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody representatio Basiliximab monoclonal antibody drug. Targets CD25 and is used to prevent transplant organ rejection. Generic name and stylized antibody representatiohttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/basiliximab-monoclonal-antibody-drug-targets-cd25-and-is-used-to-prevent-transplant-organ-rejection-generic-name-and-stylized-antibody-representatio-image218591244.html Sirolimus (rapamycin) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula. Sirolimus (rapamycin) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-image-sirolimus-rapamycin-immunosuppressive-drug-molecule-used-to-prevent-167710416.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula. Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-image-rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-167710344.html Sirolimus (rapamycin) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula. Sirolimus (rapamycin) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-image-sirolimus-rapamycin-immunosuppressive-drug-molecule-used-to-prevent-167704846.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula. Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Skeletal formula.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-image-rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-167704793.html Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Conve Rapamycin (sirolimus) immunosuppressive drug molecule. Used to prevent transplant rejection and in coronary stent coating. Convehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-molecule-used-to-prevent-75686789.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184829.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184810.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184819.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184820.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184831.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184822.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184826.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184827.html Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coating Rapamycin (sirolimus) immunosuppressive drug, chemical structure. Used to prevent transplant rejection & coronary stent coatinghttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rapamycin-sirolimus-immunosuppressive-drug-chemical-structure-used-59184832.html Recent searches: Search Results for Interleukin 2 Stock Photos and Images  (47) Page 1 of 1 1